Irbesartan CAS 138402-11-6 Puritas >99.0% (HPLC) API Factory Antihypertensive
Manufacturer Supple, Puritas, Commercial Productio
| Nomen chemicum | Irbesartan |
| Synonyma | BMS-186295;SR-47436;Aprovel;Avapro;2-Butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en- 4-unus;2-Butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one |
| CAS Number | 138402-11-6 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C25H28N6O |
| M. Pondus | 428.54 |
| Density | 1.30±0.10 g/cm3 |
| Solubilitas in aqua | Insolubilis in aqua |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Proprium | Alba ad Off-White Crystallinum Pulvis, in alcohole et in methylene chloride leviter solutum, in aqua fere solubile. |
| Lepidium sativum infrared effusio | spectrum IR servato spectro Irbesartan RSq |
| Lepidium sativum 2 | Retentionis tempus maioris cacuminis in chromatogrammo primordium correspondet Irbesartan RS. |
| Puritas / Analysis Methodus | >99.5% (HPLC) |
| Aqua | <0.50% |
| Metalla gravis | <0.002% |
| Residere in Ignition | <0.10% |
| Substantiae cognatae | (Per HPLC) |
| USP immunitas A | <0.20% |
| Quis Unidentified immunditia | <0.10% |
| Totalis immunditias | <0.50% |
| Organic VolatileImpurities | Metum USP |
| Residua Azide | <10ppm |
| RELICTUM Solvents | (Per GC) |
| Ethanol | <5000ppm |
| Toluene | <890ppm |
| Dichloromethane | <3000ppm |
| N,N-Dimethylformamide | <880ppm |
| T-Butyl Methyl Ether | <5000ppm |
| Assay | 98.0 ~ 102.0% (in anhydrous ratione fundamenti) |
| Test Standard | Enterprise Latin;USP Standard |
| Consuetudinem | API;Antihypertensive;Nam curatio hypertensionis |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Irbesartan (CAS: C) est angiotensin II receptor contra hypertensionem maxime adhibitus.Irbesartan a Sanofi Research (nunc Sanofi-Aventis pars).Communiter venales sunt a Sanofi-Aventis et Bristol-Myers Squibb sub nominibus commercii Aprovel, Karvea et Avapro.Irbesartan princeps sanguinem pressura tractare adhibetur.Avapro in Germania, UK et in US hypertensio est deductae.Ut per omnes angiotensin II receptor antagonistarum, irbesartan indicatur curationi hypertensionis.Irbesartan progressionem nephropathiae diabeticae etiam morari potest et etiam indicatur ad reductionem morbi renalis progressionem in patientibus speciebus 2 diabete, hypertensione et microalbuminuria (>30 mg/24 horae) vel proteinuria.Irbesartan etiam electricam retexere myocardii potest minuere, ita mortalitatem aegrorum hypertensione minuere, est medicamentum efficacissimum ad curationem hypertensionis et morbi cardiovascularis.
